Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin.

Nazli BahramiShakila JabeenAndliena TahiriTorill SauerHilde Presterud ØdegårdStephanie Beate GeislerBerit GravdehaugLaurens Cornelus ReitsmaKnut SelsåsVessela KristensenJürgen Geisler

Published in: Breast cancer research and treatment (2021)

Registered on March 23rd 2015 in the National trial database of Norway (Registration number: REK-SØ-84-2015).

Keyphrases

anti inflammatory drugs
study protocol
phase iii
clinical trial
quality improvement
phase ii
adverse drug
emergency department
randomized controlled trial